Refresh
500087 CIPLA Group (A)
Cipla Ltd. LIVE on BSE (View NSE)
Add to watchlist
|
408.25
-6.75
-1.63%
|
HOW HOT IS THIS STOCK?  Last 15 days data © Rediff.com |
Refresh
CIPLA
Cipla Ltd. LIVE on NSE (View BSE)
Add to watchlist
|
408.50
-6.35
-1.53%
|
HOW HOT IS THIS STOCK? Last 15 days data © Rediff.com |
Realtime news for Cipla Ltd. (See all 524 news)
24 May 2013, 18:46
New drug policy: Consumers gain, companies to feel the heat - 4 day(s) ago
Cipla FY13 results on May 29, 2013 - 3 day(s) ago
Changing global strategy outweighs India concerns for Cipla - 3 day(s) ago
Pharma shares fall on new drug policy - 3 day(s) ago
Market Voices for Cipla Ltd. (See all 154 market voices)
Expert Voices
- 17 May 2013 Buy
#Cipla-Ltd
with a target of Rs 450 & stop loss of Rs 415- Sandeep Wagle, Aptart. (ET Now)#money
Alok Kumar
- 3 hour(s) ago After Ranbaxy Sunpharma, wockhard, This is the next inline to dive down. Be aware.
#Cipla-Ltd
BSE Announcements from Cipla Ltd. (See all)
FY13 results on May 29, 2013 - 3 day(s) ago
Updates on Acquisition - 15 May 2013
Company details for Cipla Ltd.
Report Card
PE Ratios
29.65
EPS (Rs.)
14.00
Sales (Rs. Cr)
2,070.49
Face Value (Rs.)
2
Net Profit
Margin (%)
Margin (%)
15.92
Last Bonus
3:2
Last Dividend(%)
100
Return on
Average Equity
Average Equity
14.9
Research Centre
Results: Quarterly | Half Yearly | Annual
Statements: Balance Sheet | P&L | Cash Flow More: Dividend | Bonus | Share Holding | Capital Structures | Ratios
Statements: Balance Sheet | P&L | Cash Flow More: Dividend | Bonus | Share Holding | Capital Structures | Ratios
Mutual Funds Invested
Compare Cipla Ltd. with other stocks
Cadila Healthcare Ltd.
786.55
Ipca Laboratories Ltd.
582.85
Glenmark Pharmaceuticals Ltd.
563.00
Divi's Laboratories Ltd.
994.65
Wockhardt Ltd.
1,644.05
Biocon Ltd.
279.75
Dr. Reddy's Laboratories Ltd.
2,056.55
Strides Arcolab Ltd.
885.10
Sun Pharmaceutical Industries Ltd.
1,001.90
Lupin Ltd.
768.50
Show less companies © 2013 Rediff.com India Limited. All rights reserved. Disclaimer - Terms of Service - Privacy Policy - Feedback